Klingman & Associates’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDS
HPC
SVWAG
CAI
Klingman & Associates's IBDS Position: Q1 2026 in Review
Klingman & Associates sold out of iShares iBonds Dec 2027 Term Corporate ETF (IBDS) in Q1 2026, closing a stake of 1,027,244 shares — an estimated $24.9M sold.
Klingman & Associates first reported a position in IBDS in Q2 2022 and held it in 9 quarters. The position peaked at $24.9M in Q4 2025. 428 funds tracked by Wall St. Rank hold IBDS as of Q1 2026.
- Klingman & Associates reported no remaining iShares iBonds Dec 2027 Term Corporate ETF position as of Q1 2026 after selling out during the quarter.
- Klingman & Associates sold 1,027,244 iShares iBonds Dec 2027 Term Corporate ETF shares in Q1 2026, an estimated $24.9M.
- Klingman & Associates first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q2 2022 and held it in 9 quarters.
- Klingman & Associates's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $24.9M in Q4 2025.
- 428 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q1 2026.
Based on Klingman & Associates's 13F filing for Q1 2026, filed 14 May 2026.